NEW YORK, Jan. 24, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dr. Reddy's Laboratories Limited ("Dr. Reddy's" or the "Company") (NYSE: RDY). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/rdy.
The investigation concerns whether certain statements issued throughout 2015 by Dr. Reddy's complied with federal securities laws. In November, 2015, Dr. Reddy's revealed it was issued a warning letter from the Food and Drug Administration regarding three of its manufacturing facilities.
If you are aware of any facts relating to this investigation, or purchased Dr. Reddy's American Depository Receipts before November 9, 2015, you can assist this investigation by visiting the firm's site: www.bgandg.com/rdy. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-dr-reddys-laboratories-limited-rdy-300395718.html
SOURCE Bronstein, Gewirtz & Grossman, LLC